GlassScriptPhysician profile
Wendell Parkey
NPI 1053350611
$849.04
in general payments reported to CMS, 2019-2025
19 companies · $78.94 in 2025
The $78.94 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $69.23 · 2021: $55.73 · 2022: $150 · 2023: $147 · 2024: $209 · 2025: $78.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.38 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $150.97 | 2019-2024 | Strensiq |
| Mylan Specialty L.P. | $124.21 | 2021-2024 | Yupelri |
| Astellas Pharma US INC | $85.00 | 2023 | |
| Abbvie INC. | $79.71 | 2020-2024 | |
| Amgen INC. | $75.92 | 2021-2024 | Evenity, Prolia |
| Merck Sharp & Dohme LLC | $33.55 | 2020-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Minerva Surgical, INC | $32.17 | 2022 | |
| Supernus Pharmaceuticals, INC. | $30.19 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $28.84 | 2023-2025 | Farxiga, Airsupra |
| Biogen, INC. | $24.89 | 2025 | Zurzuvae |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.50 | 2022 | |
| Integra Lifesciences Corporation | $22.27 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organon LLC | $21.65 | 2025 | Jada System |
| Novo Nordisk INC | $21.41 | 2019 | |
| Shield Therapeutics INC | $21.34 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.01 | 2022 | |
| Verona Pharma, INC. | $18.72 | 2025 | Ohtuvayre |
| Innovation Technologies INC | $18.13 | 2023 | Irrisept |
| Sanofi Pasteur INC. | $16.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendell Parkey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.